Clinical Viewpoint – The Utility and Impact of GlycoMark Testing

In our September THE MARK newsletter, we are pleased to include an interview with Dr. Sam Fereidouni, the current Medical Director of Aveon Health in Scottsdale, Arizonia and former president of the ADA for Arizona.

Sam Fereidouni, MD, MHSA

Medical Director
Aveon Health
Scottsdale, Arizona



About Aveon Health:

Aveon Health uses the most advanced medical science and technology possible to provide cutting-edge medical treatment for individuals and their families. Their physicians specialize in the care of Diabetes and are dedicated to helping their patients manage the disease.



How would you describe your practice?

At Aveon health, we focus on diabetes management though our services include children’s care (including newborn), full women’s care, hypothyroidism, weight loss, metabolic disease, and more. Aveon Health was created with a very specific plan in mind – to provide quality, compassionate care to those in need.

Our practice sees approximately 10,000 patients a year and it is our mission to provide all of the care and education that our patients require under one roof so that we can tackle health issues together, head-on.


In which patients do you obtain a GlycoMark test result?

I routinely order a GlycoMark test in all patients with diabetes, which is every 3 months in advance to their visit.


How do you use the GlycoMark test?

I view diabetes as a 3D object; you don’t know the truth about glycemic control without looking at it from different angles.  I use glucose, A1C, continuous glucose monitoring and GlycoMark.  Each test confirms or refutes what is happening, no one test tells you everything.  I use the GlycoMark test to help understand glycemic patterns and to better manage my patients. With closer examination and using the GlycoMark test, you begin to see more.


What impact has the GlycoMark test had on your practice and your patients?

In today’s environment, with population management and accountable care, many clinicians are waking up to the fact that you need to get patients to goal or you’re not getting paid for services.

By including GlycoMark in the management of our patients with diabetes, our practice has been recognized by national, regional and private payors for exceeding national goals, and recently was also recognized by the American Heart Association for patient risk reduction of chronic diseases including congestive heart failure, myocardial infarction and stroke.

For my practice, GlycoMark has helped:

  • Achieve important quality measures for providing quality care that allows us to invest in our practice and people, and
  • Increase patient confidence in the care we provide to help sustain long-term relationships with our patients.

And, for my patients, the GlycoMark test has helped:

  • Provide another guide to drive patient compliance,
  • Get patients to goal, and
  • Achieve better patient outcomes.

I’d like to add that we are a group of Family Physicians, not Endocrinologists.  If we can achieve these healthcare goals, it is possible for other primary care practices to do this, as well.


How do you educate patients on the test and test results?

Patients should not give up on their achieving their health goals.  I explain that it is important to use a combination of tests together to know the true nature of glycemic control – hyperglycemia, variability and postprandial control.  An abnormal (low) GlycoMark test result means they are still having issues, perhaps in spite of treatment, and needs to be further investigated or addressed, or there may be a compliance issue.  A normal (high) or trending higher GlycoMark test means the steps they are taking are improving their control and gives both of us greater confidence in the approaches we are taking.  GlycoMark helps provide another tool to help in the education and relationship building that is important to our patients, their care and our practice.



About Dr. Fereidouni:

Dr. Fereidouni, a Family Medicine doctor by training, focuses almost exclusively on diabetes. He is the former president of the ADA for Arizona, part of the diabetes coalition for the state and one of the few members of the American Association of Clinical Endocrinologists who is not an endocrinologist. He possesses a diverse background in medical informatics and educational multimedia, and holds a Masters in Health Services Administration.

Dr. Fereidouni focuses his passion for clinical medicine, technology, and business administration to improve the care of his patients through awareness and effective treatment. He speaks nationally on advances in diabetes care, hypertension, lipid management and related diseases.



Subsequent to incorporating the GlycoMark test into clinical practice, the physician became a paid clinical consultant of GlycoMark.

For full GlycoMark prescribing information please see our package insert.